X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
http://www.business-standard.com/article/companies/us-firm-enters-patent-settlement-deal-with-dr-reddy-s-for-drug-qsymia-117090100738_1.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-23-2017-1503459270.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204663
https://www.pharmacompass.com/pdf/news/kvk-tech-inc-generic-phentermine-hydrochloride-receives-approval-in-us-1490160529.pdf
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206342
https://www.pharmacompass.com/pdf/news/avanthi-inc-generic-phentermine-hydrochloride-approved-in-us-1473939022.pdf
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0574-2016&w=01272016&lang=eng
http://cphi-online.com/future-obesity-drugs-must-provide-improved-news038407.html
http://www.fiercepharma.com/story/more-formulary-exclusions-are-their-way-smaller-pbms-get-action/2015-12-02
http://www.fiercepharmamarketing.com/story/are-takedas-900-contrave-reps-worth-it-maybe-not-analyst-says/2015-11-09
http://www.fiercepharma.com/story/vivus-counts-25m-q3-sales-300m-debt-how-can-it-possibly-cover-200m-plus-qsy/2015-11-05
http://www.fiercepharma.com/story/investors-cheer-arena-forces-out-ceo-and-cofounder/2015-10-06
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1371-2015&w=09022015&lang=eng
http://www.fiercepharma.com/story/express-scripts-stiff-arms-azs-onglyza-vivus-qsymia-new-2016-formulary/2015-08-03
http://www.fiercepharma.com/story/flailing-vivus-halves-hard-hit-qsymia-sales-force-revenue-lags/2015-07-31
http://pharmaceuticals.einnews.com/pr_news/260316327/vivus-files-lawsuit-against-teva-for-infringement-of-qsymia-patents
http://blogs.wsj.com/pharmalot/2015/04/02/vivus-goes-on-a-diet-sales-reps-are-cut-but-will-fda-help-save-money/
http://www.fiercepharma.com/story/eisai-gets-ema-nod-lenvima-just-weeks-after-fda-approval/2015-03-27
http://www.medpagetoday.com/Endocrinology/Diabetes/50672?xid=nl_mpt_DHE_2015-03-27&eun=g655567d0r&userid=655567&mu_id=5789356
http://www.wsj.com/articles/weight-loss-drugs-seek-acceptance-from-patients-and-physicians-1426526252
http://www.fiercepharmamarketing.com/story/endo-ends-stendra-marketing-pact-leaving-vivus-lurch/2016-01-03
Market Place
Share 
